The global market for hospital-acquired infection control, which involves implementing various cleaning, sterilization, and disinfection methods to minimize infection transmission risks within healthcare facilities, has shown consistent growth and this trajectory is expected to persist over the coming years.
The market value is estimated to rise from $33.01 billion in 2023 to $34.35 billion in 2024, indicating a compound annual growth rate (CAGR) of 4.1%. Several factors contribute to the market’s expansion, including growing antibiotic resistance, increased awareness of infection control measures, stringent regulations, global spread of infectious diseases, and initiatives focusing on patient safety.
A steady escalation of this market is projected in the forecast period, with an anticipated value of $41.37 billion by 2028, denoting a CAGR of 4.8%. This expansion is believed to be driven by the emergence of multidrug-resistant pathogens, pandemic preparedness, heightened surveillance and monitoring, implementation of antimicrobial stewardship programs, and improved international collaboration.
Rising healthcare expenditure is another significant factor fueling the growth of the hospital-acquired infection control market. Enhanced funding is facilitating the adoption of advanced infection prevention technologies, such as innovative disinfection systems and smart monitoring devices. Efforts to improve patient safety and reduce the prevalence of hospital-acquired infections continue to encourage investment in these state-of-the-art technologies.
Key industry players in this market arena include Johns & Johnson, P&G Professional, Honeywell International Inc., MMM Group, 3M Company, and Becton Dickinson and Company, among others. These companies are focusing on developing innovative products, including digital platforms, to bolster their profitability. These technological solutions aid in effectively managing, monitoring, and improving infection prevention and control measures within healthcare settings.
The report released by The Business Research Company presents an in-depth look into this promising market. It features a comprehensive view of historic and future periods, an evaluation of economic factors impacting the market, regional analyses, and country-specific market assessments, among other crucial aspects. With deep insights into potential opportunities and strategies, this report serves as a valuable resource for understanding segments with the greatest growth potential. It’s a must-read for healthcare professionals and infection preventionists looking to stay informed and make strategic decisions in the evolving global hospital-acquired infection control market.